An effective immunotherapy approach for ovarian cancer

Ovarian cancer affects over a quarter million women in the U.S., with most diagnoses at late stages, limiting effective treatment options. This team employs electrostatically assembled layer-by-layer nanoparticles that target disseminated tumors to safely deliver an immunostimulatory treatment to the surface of cancer cells. This mounts a strong immune defense against tumors. Deployment of this therapy could enhance therapeutic efficacy, introduce a memory response that addresses recurrence, and minimize treatment toxicity.